Bausch Health Companies Inc (NYSE:BHC)
$ 6.88 -0.07 (-1.01%) Market Cap: 2.53 Bil Enterprise Value: 23.87 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Bausch Health Companies Inc at Piper Jaffray Healthcare Conference Transcript

Dec 03, 2019 / 03:30PM GMT
Release Date Price: $28.27 (-0.95%)
David A. Amsellem
Piper Jaffray Companies, Research Division - MD and Senior Research Analyst

Okay. Let's get started. David Amsellem again from the specialty pharma team at Piper Jaffray. Our next fireside chat is Bausch, and with us today is, CEO, Joe Papa. Joe, thanks very much for joining...

Joseph C. Papa
Bausch Health Companies Inc. - CEO & Chairman of the Board

Pleasure to be here.

Questions & Answers

David A. Amsellem
Piper Jaffray Companies, Research Division - MD and Senior Research Analyst

Joining us again this year. And there's a lot to talk about in 25 minutes, so we'll just try to dive right in.

The first question, and it's going to come up so I might as well get it out of the way first is just talk about the balance sheet. What I wanted to ask is specifically what you can and can't do regarding the addition of assets. TRULANCE admittedly was a great add. And certainly, you're acting and looking at bolt-ons. But help us understand your latest thought process here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot